ARCHIVES

FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

DCT Board Okays Concepts For New Radiation Studies

June 12, 1987

Senate confirms Crawford as FDA commissioner.

July 22, 2005

Biostatisticians Write To Varmus Asking NCI To Investigate

July 23, 2010

Interferon “Hysteria” Prompts ASCO To Warn Against Expecting Immediate Benefits

June 20, 1980

NCI To Fund About 4,100 Grants; Increase Planned In Average Costs; Paylines Stable

November 20, 1998

More Than 450 Mammography Facilities Are Accredited By American College of Radiology

April 7, 1989